Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This is a predicted **long non-coding RNA transcript** annotated as "novel transcript, antisense to RP4-796B4.5." It does not encode a known protein, does not belong to any established molecular family such as receptor, enzyme, transporter, or transcription factor, and has no known biological function or clinical relevance as a drug target. There is no evidence of disease association, biomarker value, or pharmacological interaction for this transcript. Its name indicates it is oriented antisense to the RP4-796B4.5 locus, but further experimental validation and characterization would be required to assign any specific biological or therapeutic role. No functional or disease role information is currently available for this transcript in major genomic or pharmacological resources[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to RP4-796B4.5 (ENSG00000295077 (or LOC105378733)).